Screener
Perrigo Company PRGO Infant Formula — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Perrigo Company in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Perrigo Company’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 1:44 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001585364-26-000145
| Line item | Three Months Ended June 28, 2025 / Self Care | Three Months Ended June 28, 2025 / Specialty Care | Three Months Ended June 28, 2025 / Infant Formula | Reporting Segments Total |
|---|---|---|---|---|
| Reporting segment net sales(2) | 598.6 | $233.1 | $82.0 | $913.6 |
| Adjusted cost of sales | 397.1 | 98.1 | 71.2 | |
| Adjusted other expense items(3) | 107.6 | 68.7 | 23.0 | |
| Segment operating income (loss) | $93.9 | $66.3 | $(12.2) | $148.0 |
| Reconciliation to Income from continuing operations before income taxes: | ||||
| All Other adjusted operating income | 25.7 | |||
| Unallocated expense | (38.5) | |||
| Amortization expense related primarily to acquired intangible assets | (56.8) |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Perrigo Company's infant formula — cost of sales?
- Perrigo Company (PRGO) reported infant formula — cost of sales of $80.2M in Q2 2026.
- What does infant formula — cost of sales mean?
- This represents the direct costs attributable to the production and distribution of infant formula products, including raw materials, labor, and manufacturing overhead. It is a primary indicator of the segment's production efficiency and input cost management. Monitoring this helps evaluate the gross margin potential of the infant nutrition business.
Ask your AI about Perrigo Company's infant formula — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude